MN-305
MN-305 Uses, Dosage, Side Effects, Food Interaction and all others data.
MN-305 is a novel, potent and highly selective serotonin 5-HT1A receptor agonist under development by MediciNova for the treatment of anxiety disorders beginning with Generalized Anxiety Disorder (GAD).
| Trade Name | MN-305 |
| Generic | MN-305 |
| Type | |
| Formula | C19H22ClNO5 |
| Weight | Average: 379.835 Monoisotopic: 379.118650526 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in anxiety disorders, depression, insomnia, and neurologic disorders.
How MN-305 works
MN-305 is a potent and highly-selective full agonist at the serotonin 5-HT1A receptor under development by MediciNova both for the treatment of insomnia, as well as for anxiety disorders such as Generalized Anxiety Disorder (GAD). MN-305 has been evaluated in an extensive preclinical toxicology program which showed no evidence of inducing genetic mutations, immune response or cancer. MN-305 has also proved to be consistently well-tolerated in clinical safety, efficacy and pharmacokinetic studies in over 1,200 subjects.
Innovators Monograph
You find simplified version here MN-305
